Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 30582924.
- Also identified by DOI 10.1016/j.athoracsur.2018.11.047.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post-cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.
Medical subject headings
- Angiotensin II
- Cardiopulmonary Bypass
- Vasoplegia